Skip to content

Vilon

Human clinical Immune Support 3 sources

Vilon is a synthetic dipeptide (Lys-Glu) developed by the St. Petersburg Institute of Bioregulation and Gerontology. Research indicates it has strong immunomodulatory properties, stimulating thymus function, enhancing T-cell activity, and showing potential in treating immunodeficiencies and age-related immune decline.

01Dosing reference

Amount
1-2 mg/day
Frequency
Once daily
Cycle
10-20 days on, followed by a multi-month break
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Chromatin Uncoiling

Vilon penetrates the cell nucleus and binds to DNA, promoting the uncoiling of chromatin in specific gene regions.

02

Gene Expression Modulation

This interaction stimulates the transcription of genes responsible for immune function, particularly those related to T-lymphocyte differentiation.

03

Immune System Activation

The resulting increase in T-cell activity and interleukin-2 production enhances the body's overall immune response and combats immunosenescence.

03Human evidence

Improved immune parameters in elderly patients, including increased T-cell counts and enhanced functional activity of immune cells.

Clinical studies conducted in Russia on older adults experiencing age-related immune decline.

Accelerated recovery and reduced complication rates in patients with secondary immunodeficiencies and chronic infections.

Observational and clinical trials in patients with compromised immune systems due to various pathologies.

04Preclinical evidence

Increased mean and maximum lifespan, along with a decreased incidence of spontaneous tumors.

Long-term studies in various strains of mice and rats evaluating geroprotective effects.

Stimulation of interleukin-2 (IL-2) production and enhanced proliferation of lymphocytes.

In vitro studies using spleen cell cultures from immunodepressed animals.

05What is known vs. unknown

Reasonably established
  • Vilon is a synthetic dipeptide consisting of L-lysine and L-glutamic acid (Lys-Glu).
  • It acts primarily as an immunomodulator by stimulating T-cell immunity and thymus function.
  • Animal research demonstrates significant geroprotective effects, including increased lifespan and reduced tumor incidence.
  • It is part of the Khavinson peptides family, developed to regulate gene expression and cellular function.
Unknowns & limits
  • There is a lack of large-scale, randomized, double-blind clinical trials in Western populations.
  • The long-term safety profile and optimal dosing protocols for various conditions remain under-researched outside of its origin country.
  • Exact mechanisms of DNA binding and gene specificity require further molecular elucidation.

06Safety & regulatory context

Regulatory statusVilon is not FDA-approved for medical use and is classified as an experimental research chemical in most jurisdictions outside of Russia. In Russian clinical settings, it has been used for immune support with a reportedly favorable safety profile and minimal side effects. However, comprehensive, independent safety data from large-scale Western trials is lacking. It should be used strictly for research purposes, and individuals with autoimmune conditions should exercise caution due to its immune-stimulating properties.

07Compared with Thymalin

Vilon vs. Thymalin
Key difference
Vilon is a highly specific, synthetic dipeptide (Lys-Glu), whereas Thymalin is a complex mixture of polypeptide fractions extracted from the thymus gland of calves.
When researchers discuss each
Researchers discuss Vilon when focusing on targeted, synthetic gene modulation for immune enhancement and anti-aging, while Thymalin is referenced for broader, natural thymus extract replacement therapy.

08Glossary

Dipeptide
A simple molecule consisting of exactly two amino acids linked by a single peptide bond.
Immunosenescence
The gradual deterioration of the immune system brought on by natural age advancement.
Chromatin
A complex of DNA and proteins found in cells, which packages long DNA molecules into more compact, denser structures.

09Knowledge check

Q1Which two amino acids make up the synthetic dipeptide Vilon?
Q2What is the primary biological effect of Vilon observed in research?
Q3Which documented limitation in the dossier most directly reduces confidence that Vilon's reported clinical benefits will generalize to Western patient populations?
Q4According to the dossier, in which research context are investigators more likely to discuss Vilon rather than Thymalin?
Q5Which statement best reflects the dossier's description of Vilon's regulatory and safety status?

10Sources

More in Immune Support

See all
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.